Bill Campbell is responsible for a variety of global functions including sales, marketing, commercial development, medical affairs and public policy.
Prior to being appointed EVP, Chief Commercial Officer in 2017, Bill led CSL Behring’s North American commercial operations since joining the company in 2014.
He has more than 35 years of diverse experience across a range of therapeutic areas including, oncology, pain care and vaccines and has held senior management positions at a number of pharmaceutical and biotechnology companies.
He holds a bachelor of science degree in business administration from Western Michigan University.